Ipca lab option chain
WebAs per the NSE option chain data, the current active strikes for the F&O contracts of Ipca Laboratories Ltd Industries range from 778.05 to 798.40. It is important to note that not … WebPharmaceuticals Open Interest Top Contracts Option Chain Options Summary IPCA Laboratories Options Expiry: At the Money IV 45.34 IV Change % 54.23% Days for Expiry 15 Expiry 28 Sept Market Lot 500 PCR + 1.50 In The Money Open Interest (OI) 13,42,837 Change in OI +45,671 OI Change % (0.28%) Trade Volume 4,12,837 Out the Money …
Ipca lab option chain
Did you know?
WebIPCA Laboratories Limited Stock Price Today, Live NSE Share Price: Get the latest IPCA Laboratories Limited news, company updates, quotes, tips, historical charts, 52 week … WebDetailed Futures and Options (F&O) analysis of Ipca Laboratories (IPCALAB) with Option chain, premium, discount , open Interest, contract details, put/call trade activity, max traded Strike price, futures pivot Point, expiry date, Lot size.
Web21 mrt. 2024 · Ipca Laboratories Ltd. had last split the face value of its shares from Rs 2 to Rs 1 in 2016.The share has been quoting on an ex-split basis from Jan. 10, 2024. See all forthcoming Bonus and split Is Ipca Laboratories Ltd. worth buying? 324 Votes: Buy 80.25% Sell 8.95% Hold 10.8% BUY SELL HOLD RESEARCH REPORTS Hold SEE … Web15 nov. 2000 · Corporate actions: Dividend history for Ipca Laboratories Ltd. Ipca Laboratories Ltd. has declared 38 dividends since Nov. 15, 2000. In the past 12 months, Ipca Laboratories Ltd. has declared an equity dividend amounting to Rs 4.00 per share. At the current share price of Rs 784.05, this results in a dividend yield of 0.51%. See all …
WebDetailed Futures and Options (F&O) analysis of Ipca Laboratories (IPCALAB) with Option chain, premium, discount , open Interest, contract details, put/call trade activity, max … WebIPCA Laboratories Limited Future Derivatives: Get the latest updates on IPCA Laboratories Limited Derivatives, Future Quotes Options, F&O Analysis, Strategy, …
Web16 mrt. 2024 · Promoters holding remains unchanged at 46.29% in Dec 2024 qtr. FII/FPI have decreased holdings from 10.57% to 10.46% in Dec 2024 qtr. Number of FII/FPI investors decreased from 250 to 245 in Dec 2024 qtr. Mutual Funds have increased holdings from 29.71% to 29.79% in Dec 2024 qtr. Number of MF schemes remains unchanged at …
WebYes, you can sell put options of IPCA Laboratories without owning the underlying stock. But you will end up in a short position. Remember, you’ve essentially borrowed stocks with the intention of returning them later on if you’ve sold a … dany therrienWebipca laboratories ltd Option Chain - Get the latest news & updates on ipca laboratories ltd Option Chain, along with the live charts at ICICI Direct. Visit now and start trading in … birthed or bornWebIpca Laboratories Ltd Share Price Ipca Share Price IPCALAB 29 JUN OPTION ₹ 13.55 --- Company Overview Option Chains Investment Calculators FAQ's Ipca Laboratories Ltd Quick Overview Open ₹0.00 Close -- Circuit Range ₹91- ₹202.40 Day Range ₹0.00- ₹0.00 Volume 148,500.00 Avg. Traded ₹14.84 Spot 13.55 OI 315,000 Change in Ol -- dany targaryen actressWeb1 apr. 2024 · - Trade Support Toll Free no : 1800 266 0050 (Select IVR option 1) Charged no : 022 68645400/ 022 50998100 (Select IVR option 1) Timings : 8:00 AM to 2:00 AM on subsequent day (Monday to Friday) - Member Compliance Support Toll Free no : 1800 … dany targaryen brotherWebIpca Laboratories Option Chain : Ipca Labs. Call Put Option India Infoline Home Share Market Stocks Ipca Laboratories Ltd IPCALAB Option Chain Ipca Laboratories Ltd … birth editorial boardWebIpca Laboratories is a leading pharmaceutical company across the continents that work on its core values of quality, safety, integrity, dignity, ... With a reliable supply chain and cost competitiveness in the dynamic market, Ipca has emerged as one of … dany therrien remaxWeb17 feb. 2024 · View 16 reports from 5 analysts offering long term price targets for Ipca Laboratories Ltd.. Ipca Laboratories Ltd. has an average target of 949.80. The consensus estimate represents an upside of 13.30% from the last price of 838.30. Reco - This broker has downgraded this stock from it's previous report. dany theze